Olon and CimCure partner for Phase I aseptic manufacturing of novel squalene-adjuvanted cancer vaccine
Italian biopharmaceutical manufacturer Olon has announced a collaboration with Dutch biotech CimCure BV to provide aseptic filling services for CimCure's novel cancer vaccine